OVERBROOK MANAGEMENT CORP Celldex Therapeutics, Inc. Transaction History

OVERBROOK MANAGEMENT CORP portfolio value:

$227,000
portfolio value

OVERBROOK MANAGEMENT CORP quarter portfolio value change:

+4.27%
quarter

Celldex Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -2.00% -165 shares 5K $28.11 8.07K
Q2 2022 share 0.00% 0 shares -59K $26.96 8.24K
Q1 2022 share Increase 0.00% 8.24K shares 281K $34.06 8.24K